Your browser doesn't support javascript.
loading
Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf-DAPK Complex by Raf Inhibitor Combination Therapy.
Tsai, Yi-Ta; Chuang, Mei-Jen; Tang, Shou-Hung; Wu, Sheng-Tang; Chen, Yu-Chi; Sun, Guang-Huan; Hsiao, Pei-Wen; Huang, Shih-Ming; Lee, Hwei-Jen; Yu, Cheng-Ping; Ho, Jar-Yi; Lin, Hui-Kuan; Chen, Ming-Rong; Lin, Chung-Chih; Chang, Sun-Yran; Lin, Victor C; Yu, Dah-Shyong; Cha, Tai-Lung.
Afiliação
  • Tsai YT; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China. Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Chuang MJ; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Tang SH; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Wu ST; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Chen YC; Division of Urology, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan, Republic of China.
  • Sun GH; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China. Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institutes of Life Sciences, National Def
  • Hsiao PW; Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan, Republic of China.
  • Huang SM; Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Lee HJ; Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Yu CP; Graduate Institutes of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Ho JY; Graduate Institutes of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institute of Pathology and Parasitology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Lin HK; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.
  • Chen MR; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institutes of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Lin CC; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
  • Chang SY; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. Taipei City Hospital, Taipei, Taiwan, Republic of China.
  • Lin VC; Division of Urology, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan, Republic of China.
  • Yu DS; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China. Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institutes of Life Sciences, National Def
  • Cha TL; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China. Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institutes of Life Sciences, National Def
Cancer Res ; 75(17): 3568-82, 2015 Sep 01.
Article em En | MEDLINE | ID: mdl-26100670
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Proteínas Proto-Oncogênicas c-raf / Sinergismo Farmacológico / Proteínas Quinases Associadas com Morte Celular / Neoplasias Renais Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Proteínas Proto-Oncogênicas c-raf / Sinergismo Farmacológico / Proteínas Quinases Associadas com Morte Celular / Neoplasias Renais Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China